Vertex Pharmaceuticals (VRTX) EV/EBITDA history

Above its usual rangeAs of

VRTX's EV/EBITDA of 25.2x is higher than 84% of its available weekly readings from the last five years.

12.9x21.9x31.0x Median 25.2x 2021202320252026
12.9x21.9x31.0x Median 25.2x 2021202320252026
12.9x21.9x31.0x Median 25.2x 2021202320252026
12.9x21.9x31.0x Median 25.2x 2021202320252026

Oct 25, 2021 to Oct 19, 2026. Shading: middle half of five-year readings.

Explore VRTX on stockresearch.app